Literature DB >> 12032850

Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis.

Chaitanya S Bangur1, Ann Switzer, Liqun Fan, Matthew J Marton, Michael R Meyer, Tongtong Wang.   

Abstract

To identify genes that are differentially over-expressed in Small Cell Lung Carcinoma (SCLC) we have used a combination of suppression subtractive hybridization and cDNA microarray to analyse the expression profiles of 2400 cDNAs clones. Genes that are over-expressed in SCLC were identified using 32 pairs of fluorescence-labeled cDNA samples representing various lung tumors and normal tissues. This comprehensive approach has resulted in the identification of 209 genes that are differentially over-expressed in SCLC. Quantitative real-time PCR was used to further validate the expression of 43 genes in SCLC tumors and various normal tissues. Discussed in this report are nine genes, which showed the most promising SCLC tumor to normal tissue differential expression profiles, including seven known and two novel genes. The large number of differentially expressed genes identified from this analysis and the characterization of these genes will provide valuable information in better understanding the biology of SCLC and help us in developing these gene products as potential targets for diagnostic as well as therapeutic usage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032850     DOI: 10.1038/sj.onc.1205480

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Identification of differently expressed genes in human colorectal adenocarcinoma.

Authors:  Yao Chen; Yi-Zeng Zhang; Zong-Guang Zhou; Gang Wang; Zeng-Ni Yi
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

2.  UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.

Authors:  Galina A Stepanyuk; Pedro Serrano; Eigen Peralta; Carol L Farr; Herbert L Axelrod; Michael Geralt; Debanu Das; Hsiu-Ju Chiu; Lukasz Jaroszewski; Ashley M Deacon; Scott A Lesley; Marc-André Elsliger; Adam Godzik; Ian A Wilson; Kurt Wüthrich; Daniel R Salomon; James R Williamson
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-03-24       Impact factor: 7.652

3.  Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.

Authors:  Dingmiao Wang; Ting Hao; Yang Pan; Xiaowei Qian; Daixing Zhou
Journal:  Mol Cell Biochem       Date:  2015-01-08       Impact factor: 3.396

Review 4.  Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Authors:  Jennifer A Byrne; Sarah Frost; Yuyan Chen; Robert K Bright
Journal:  Tumour Biol       Date:  2014-05-06

5.  CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Authors:  Anke H Sillars-Hardebol; Beatriz Carvalho; Jeroen A M Beliën; Meike de Wit; Pien M Delis-van Diemen; Marianne Tijssen; Mark A van de Wiel; Fredrik Pontén; Gerrit A Meijer; Remond J A Fijneman
Journal:  Cell Oncol (Dordr)       Date:  2012-06-19       Impact factor: 6.730

Review 6.  Novel strategies for the treatment of small-cell lung carcinoma.

Authors:  William N William; Bonnie S Glisson
Journal:  Nat Rev Clin Oncol       Date:  2011-06-21       Impact factor: 66.675

7.  Novel therapeutic approaches for small cell lung cancer: the future has arrived.

Authors:  Maria Catherine Pietanza; Charles M Rudin
Journal:  Curr Probl Cancer       Date:  2012-04-10       Impact factor: 3.187

8.  Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion.

Authors:  Seyed Mehdi Jafarnejad; Aijaz Ahmad Wani; Magdalena Martinka; Gang Li
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

9.  Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study.

Authors:  Jens Neumann; Friedrich Feuerhake; Gian Kayser; Thorsten Wiech; Konrad Aumann; Bernward Passlick; Paul Fisch; Martin Werner; Axel Zur Hausen
Journal:  BMC Cancer       Date:  2010-03-02       Impact factor: 4.430

10.  POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.

Authors:  J M Fortier; J E Payton; P Cahan; T J Ley; M J Walter; T A Graubert
Journal:  Leukemia       Date:  2010-04-08       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.